Solutions

Clinical solutions

Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions

Consulting & Commercial

Asset Development Consulting Commercial Positioning Language Services Real World Intelligence Regulatory Affairs Symphony Health data

Case studies
Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

Technologies
Technology solutions from early phase through to post-marketing.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

More than monitoring
How modern monitoring paradigms impact CRA roles

Meeting requirements for Joint Clinical Assessments
A planning guide for health technology developers

Accelerating clinical development through digital health technologies
Digital health technologies provide a roadmap for modernising clinical trials
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

Beyond the bench: The advantages of GMP over USP compounding in early phase development
6 November 2025. Register now.

Strategic approaches for early clinical trials in neurodegenerative diseases
18 November 2025. Register now.
About ICON

About ICON

Company history ICON at a glance Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality

ICON for

Patients Volunteers Investigators Jobs & Careers Investors Suppliers

Sustainability, charity, inclusion and belonging
ICON CARES is our commitment to making a positive impact on our people, environment and our community.

Healthcare Intelligence
Clinical Research. Evolved.

Careers
Investors
Investigators
Patients
Contact

Home
Insights
ICON Webinar Channel

ICON Webinar Channel

b

Home
Clinical Research Services
Commercialisation & Outcomes
Early Phase
Laboratory Webinars
Medical Device
Therapeutic Webinars

Webinar: Considerations for Oligonucleotide Therapeutics in CMC

1:01:14

Share on Facebook
Share on X
Share on LinkedIn
Share via Email

Description

Related Videos

View More

View Less

Share

Share on Facebook
Share on X
Share on LinkedIn
Share via Email

Related Videos

In Laboratory Webinars

Play video Panel Session: Bioanalysis zone

Panel Session: Bioanalysis zone

55:42
Play video Panel discussion: ADC bioanalytics

Panel discussion: ADC bioanalytics

55:22
Play video Webinar: Digital solutions to alleviate NASH clinical trial challenges

Webinar: Digital solutions to alleviate NASH clinical trial challenges

52:54
Play video Best practices for the validation of hybrid LC-MS/MS assays

Best practices for the validation of hybrid LC-MS/MS assays

55:01
Play video Panel discussion: Immunogenicity assessment of therapeutic proteins

Panel discussion: Immunogenicity assessment of therapeutic proteins

56:37
Play video Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

1:01:13

Contact
About ICON
Results & Reports

For Clients

Therapeutics
Solutions
Insights
Technologies
Content preferences
Office locations

ICON for

Patients
Volunteers
Investigators
Jobs & Careers
Investors
Suppliers

News & Events

Press releases
Mediakit
Events
Webinars

LinkedIn
Twitter
Facebook
Instagram
Youtube

© 2025 ICON plc
Disclaimer
Privacy & Data
Cookies

Share this video

Embed

Size: x pixels